Home › Companies › AngioDynamics, Inc. › 2025-2026

AngioDynamics, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and AngioDynamics, Inc.’s Form 8-K, filed November 12, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.

4Ballot items
190Asset managers
801Fund votes
November 10, 2025Meeting date

Results at a glance

Meeting of November 10, 2025: 4 items on AngioDynamics, Inc.’s Form 8-K, filed November 12, 2025: 2 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AngioDynamics, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by AngioDynamics, Inc.

These tallies are AngioDynamics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed November 12, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AngioDynamics, Inc. — official shareholder meeting results, meeting held November 10, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: James C. Clemmer	29,634,152	--	--	800,454	5,462,943	97%	Elected	—
Elect Director: Michael E. Tarnoff, MD	29,245,896	--	--	1,188,710	5,462,943	96%	Elected	—
2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026	35,727,186	156,899	13,464	--	--	99.5%	Approved	—
3. The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers	28,357,782	2,057,982	18,842	--	5,462,943	93%	Approved	—

Source: AngioDynamics, Inc., Form 8-K, filed with the SEC on November 12, 2025 — read the filing on EDGAR.

How asset managers voted at the AngioDynamics, Inc. 2025-2026 meeting

Each item below shows how the 190 asset managers that disclosed a AngioDynamics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: James C. Clemmer

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 29,634,152WITHHELD: 800,454

Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: Proposal to elect two Class I directors, for a term of three years: James C. Clemmer

AngioDynamics, Inc.’s own tally for this item (“Elect Director: James C. Clemmer”): 29,634,152 for, 800,454 withheld, per its Form 8-K filed November 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Board of Directors were elected, each as a Class I director to serve until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 9,331,457 for, 299 withheld, 1,135 abstained.

FOR

FOR: 9,331,457ABSTAIN: 1,135WITHHOLD: 299

Largest asset managers voting on “Proposal to elect two Class I directors, for a term of three years: James C. Clemmer” at AngioDynamics, Inc., 2025-2026
Asset manager	For	Withheld	Vote
Vanguard	2,076,882	0	For
BlackRock	1,612,522	0	For
TIAA	1,012,627	0	For
Fidelity	991,096	0	For
Royce	553,461	0	For
Dimensional	499,017	0	For
Charles Schwab	330,988	0	For
Segall Bryant & Hamill Trust	322,747	0	For
Transamerica	304,000	0	For
FIRST EAGLE FUNDS	243,221	0	For
PARADIGM FUNDS	200,000	0	For
Columbia Threadneedle	126,902	0	For
RBB FUND, INC.	119,724	0	For
Equitable	104,744	0	For
American Century	96,905	0	For
State Street	92,051	124	For
Dunham Funds	80,807	0	For
1290 Funds	72,465	0	For
QUANTITATIVE MASTER SERIES LLC	69,058	0	For
Lincoln Financial	62,995	0	For
Goldman Sachs	54,264	0	For
SEI	51,777	0	For
MASTER INVESTMENT PORTFOLIO	31,109	0	For
Northern Trust	25,376	0	For
AIG/SunAmerica	20,054	0	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

2. Elect Director: Michael E. Tarnoff, MD

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 29,245,896WITHHELD: 1,188,710

Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: Proposal to elect two Class I directors, for a term of three years: Michael E. Tarnoff, MD

AngioDynamics, Inc.’s own tally for this item (“Elect Director: Michael E. Tarnoff, MD”): 29,245,896 for, 1,188,710 withheld, per its Form 8-K filed November 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Board of Directors were elected, each as a Class I director to serve until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 9,319,940 for, 11,816 withheld, 1,135 abstained.

FOR

FOR: 9,319,940ABSTAIN: 1,135WITHHOLD: 11,816

Largest asset managers voting on “Proposal to elect two Class I directors, for a term of three years: Michael E. Tarnoff, MD” at AngioDynamics, Inc., 2025-2026
Asset manager	For	Withheld	Vote
Vanguard	2,076,882	0	For
BlackRock	1,612,522	0	For
TIAA	1,012,627	0	For
Fidelity	991,096	0	For
Royce	553,461	0	For
Dimensional	499,017	0	For
Charles Schwab	330,988	0	For
Segall Bryant & Hamill Trust	322,747	0	For
Transamerica	304,000	0	For
FIRST EAGLE FUNDS	243,221	0	For
PARADIGM FUNDS	200,000	0	For
Columbia Threadneedle	126,902	0	For
RBB FUND, INC.	119,724	0	For
Equitable	104,744	0	For
American Century	96,905	0	For
State Street	92,051	124	For
Dunham Funds	80,807	0	For
1290 Funds	72,465	0	For
QUANTITATIVE MASTER SERIES LLC	69,058	0	For
Lincoln Financial	62,995	0	For
Goldman Sachs	54,264	0	For
SEI	51,777	0	For
MASTER INVESTMENT PORTFOLIO	31,109	0	For
Northern Trust	25,376	0	For
AIG/SunAmerica	20,054	0	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

3. 3. The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

93% Approved · of votes cast

FOR 93%

FOR: 28,357,782AGAINST: 2,057,982

Details: description as filed, official tally, votes by 187 asset managers

Description as filed by funds: Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers.

AngioDynamics, Inc.’s own tally for this item (“3. The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers”): 28,357,782 for, 2,057,982 against — passed, per its Form 8-K filed November 12, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers was approved based upon the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 53 asset managers voting on “Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers.” at AngioDynamics, Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	2,076,882	0	For
BlackRock	1,612,522	0	For
TIAA	1,012,627	0	For
Fidelity	991,096	0	For
Royce	553,461	0	For
Dimensional	499,017	0	For
Charles Schwab	330,988	0	For
Segall Bryant & Hamill Trust	322,747	0	For
Transamerica	304,000	0	For
FIRST EAGLE FUNDS	243,221	0	For
PARADIGM FUNDS	200,000	0	For
Columbia Threadneedle	126,902	0	For
RBB FUND, INC.	119,724	0	For
Equitable	104,744	0	For
American Century	0	96,905	Against
State Street	92,175	0	For
Dunham Funds	80,807	0	For
1290 Funds	72,465	0	For
QUANTITATIVE MASTER SERIES LLC	69,058	0	For
Lincoln Financial	62,995	0	For
Goldman Sachs	54,264	0	For
SEI	51,777	0	For
MASTER INVESTMENT PORTFOLIO	31,109	0	For
Northern Trust	25,376	0	For
AIG/SunAmerica	20,054	0	For

Fund voting reports, all 53 managers: 9,228,306 for, 104,585 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 148 asset managers voting on “Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers.” at AngioDynamics, Inc., 2025-2026
Asset manager	For	Against	Vote
Point72	2,090,346	0	For
BlackRock	1,548,490	400	For
ARMISTICE CAPITAL, LLC	1,432,100	0	For
SYSTEMATIC FINANCIAL MANAGEMENT LP	1,383,060	12,605	For
Divisadero Street Capital Management, LP	1,387,470	0	For
Nuveen	1,015,147	0	For
GEODE CAPITAL MANAGEMENT, LLC	987,473	0	For
SEGALL BRYANT & HAMILL, LLC	939,525	0	For
State Street	841,349	0	For
Renaissance	666,025	0	For
PARADIGM CAPITAL MANAGEMENT INC/NY	518,200	0	For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	517,284	Against
Pier Capital, LLC	453,953	0	For
Royce	438,899	0	For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	408,061	0	For
Manatuck Hill Partners, LLC	333,058	0	For
Charles Schwab	331,038	0	For
Invesco	0	314,742	Against
Orion Porfolio Solutions, LLC	289,390	0	For
First Eagle Investment Management, LLC	277,335	0	For
Northern Trust	269,580	0	For
Two Sigma	199,707	0	For
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	196,158	0	For
KENNEDY CAPITAL MANAGEMENT LLC	194,713	0	For
MOORE CAPITAL MANAGEMENT, LP	190,675	0	For

Institutional-manager reports, all 148 managers: 18,787,519 for, 952,489 against, 1,594 not voted. Showing the 25 largest; see all in the interactive database.

4. 2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.5% Approved · of votes cast

FOR 99.5%

FOR: 35,727,186AGAINST: 156,899

Details: description as filed, official tally, votes by 53 asset managers

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accounting firm for the fiscal year ending May 31, 2026.

AngioDynamics, Inc.’s own tally for this item (“2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026”): 35,727,186 for, 156,899 against — passed, per its Form 8-K filed November 12, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2026 was approved based upon the following votes:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 9,329,848 for, 3,043 against.

FOR

FOR: 9,329,848AGAINST: 3,043

Largest asset managers voting on “To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accoun” at AngioDynamics, Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	2,076,882	0	For
BlackRock	1,612,522	0	For
TIAA	1,012,627	0	For
Fidelity	991,096	0	For
Royce	553,461	0	For
Dimensional	499,017	0	For
Charles Schwab	330,988	0	For
Segall Bryant & Hamill Trust	322,747	0	For
Transamerica	304,000	0	For
FIRST EAGLE FUNDS	243,221	0	For
PARADIGM FUNDS	200,000	0	For
Columbia Threadneedle	126,902	0	For
RBB FUND, INC.	119,724	0	For
Equitable	104,744	0	For
American Century	96,905	0	For
State Street	92,175	0	For
Dunham Funds	80,807	0	For
1290 Funds	72,465	0	For
QUANTITATIVE MASTER SERIES LLC	69,058	0	For
Lincoln Financial	62,995	0	For
Goldman Sachs	54,264	0	For
SEI	50,044	1,733	For
MASTER INVESTMENT PORTFOLIO	31,109	0	For
Northern Trust	25,376	0	For
AIG/SunAmerica	20,054	0	For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

Largest AngioDynamics, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 41,004,249 shares outstanding at the time of that meeting.

Fund voting reports: top AngioDynamics, Inc. shareholders by shares voted on “Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers.”, 2025-2026
#	Asset manager	% of shares outstanding
1	Vanguard	5.07%
2	BlackRock	3.93%
3	TIAA	2.47%
4	Fidelity	2.42%
5	Royce	1.35%
6	Dimensional	1.22%
7	Charles Schwab	0.81%
8	Segall Bryant & Hamill Trust	0.79%
9	Transamerica	0.74%
10	FIRST EAGLE FUNDS	0.59%

Institutional-manager reports: top AngioDynamics, Inc. shareholders by shares voted on “Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers.”, 2025-2026
#	Asset manager	% of shares outstanding
1	Point72	5.10%
2	BlackRock	3.78%
3	ARMISTICE CAPITAL, LLC	3.49%
4	SYSTEMATIC FINANCIAL MANAGEMENT LP	3.40%
5	Divisadero Street Capital Management, LP	3.38%
6	Nuveen	2.48%
7	GEODE CAPITAL MANAGEMENT, LLC	2.41%
8	SEGALL BRYANT & HAMILL, LLC	2.29%
9	State Street	2.05%
10	Renaissance	1.62%

Reported AngioDynamics, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

AngioDynamics, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	8.99%	13F
Point72	7.76%	13F
SYSTEMATIC FINANCIAL MANAGEMENT LP	6.12%	13G
Vanguard Group	5.94%	13F
KEVIN KOTLER	5.91%	13G
State Street	3.25%	13F
James C. Clemmer	2.73%	DEF14A
Dimensional Fund Advisors	2.31%	13F
Renaissance Technologies	1.96%	13F
Millennium Management	1.57%	13F

Percentages above are of 41,004,249 shares outstanding, as reported by AngioDynamics, Inc. on its Form 10-Q dated August 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AngioDynamics, Inc.’s 10-Q dated August 31, 2024. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At AngioDynamics, Inc.'s shareholder meeting held November 10, 2025, in the 2025-2026 proxy season, 190 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 801 separate fund positions. On the most widely held item on that ballot — Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. — AngioDynamics, Inc.'s filing reports the proposal as approved, with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AngioDynamics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on November 12, 2025.

AngioDynamics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.